Good morning :)
Soni Medicare Ltd

Soni Medicare Ltd

SML Share Price

BSE
₹69.354.99% (-3.64)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
SIP

With a market cap of ₹31 cr, stock is ranked 4,301

Stock is 4.68x as volatile as Nifty

SML Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Bad

The stock is in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

With a market cap of ₹31 cr, stock is ranked 4,301

Stock is 4.68x as volatile as Nifty

SML Performance & Key Metrics

SML Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-8.5824.13—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
43.845.870.49%

SML Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

SML Company Profile

Soni Medicare operates multi-specialty hospital in Jaipur

PE Ratio
62.82
62.82
1Y Return
9.71%
9.71%
Buy Reco %
86.67
86.67
PE Ratio
60.81
60.81
1Y Return
18.92%
18.92%
Buy Reco %
84.00
84.00
PE Ratio
92.38
92.38
1Y Return
0.61%
0.61%
Buy Reco %
66.67
66.67
PE Ratio
152.74
152.74
1Y Return
3.83%
3.83%
Buy Reco %
91.67
91.67
PE Ratio
56.36
56.36
1Y Return
22.58%
22.58%
Buy Reco %
90.00
90.00
Compare with Peers

SML Forecast

SML Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

SML

SML

Income

Balance Sheet

Cash Flow

SML Income Statement

SML Income Statement

Loading...

Quartermar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026
Total Revenue7.157.288.607.797.527.496.525.656.584.78
Operating & Other expensessubtract7.617.847.737.536.827.407.046.326.405.44
Depreciation/Amortizationsubtract0.130.120.110.120.150.130.130.130.130.13
Interest & Other Itemssubtract0.280.180.280.240.290.250.270.340.360.39
Taxes & Other Itemssubtract0.020.010.010.03-0.090.000.010.000.060.01
EPS-2.10-2.031.09-0.310.51-0.68-2.16-2.65-0.45-2.81

SML Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual report

PDF
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
 

SML Stock Peers

SML Past Performance & Peer Comparison

SML Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Soni Medicare Ltd-11.4924.13—
Apollo Hospitals Enterprise Limited62.8212.390.23%
Max Healthcare Institute Limited60.818.400.22%
Manipal Health Enterprises Limited92.389.97—
ScreenerCompare valuation on Screener

SML Stock Price Comparison

Compare SML with any stock or ETF
Compare SML with any stock or ETF
SML
Loading...

SML Holdings

SML Shareholdings

SML Promoter Holdings Trend

SML Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

SML Institutional Holdings Trend

SML Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

SML Shareholding Pattern

SML Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding69.79%0.00%0.00%0.00%30.21%

Dec 2025

Mar 2026

Jun 2026

Sep 2026

SML Shareholding History

SML Shareholding History

JunSepDec '25MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

SML Insider Trades & Bulk Stock Deals

SML Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing SML stock

smallcases containing SML stock

Looks like this stock is not in any smallcase yet.

SML Events

SML Events

SML Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

SML has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

SML Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

SML has not given any dividends in last 5 years

SML Dividends

SML Dividends

Hmm, looks like data is unavailable here. Please come back after some time

SML Stock News & Opinions

SML Stock News & Opinions

Corporate
Corporate
Soni Medicare to convene a board meeting to approve a hospital operations agreement

Soni Medicare Limited will hold a board meeting on October 26, 2026, to consider and approve a Healthcare Operations and Management (O&M) Framework Agreement with a vendor for the operations and management of Soni Hospital, a unit of Soni Medicare Limited.

2 weeks agoCapital Market - Live
Corporate
Corporate
Soni Medicare confirmed regulatory compliance for the September quarter, per a BSE filing

Soni Medicare Limited submitted a certificate to the BSE Limited on October 10, 2026, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30, 2026, as processed by its Registrar and Share Transfer Agent, MUFG Intime India Private Limited.

3 weeks agoCapital Market - Live
Corporate
Corporate
Soni Medicare restricts trading for insiders ahead of September 2026 financial results

Soni Medicare Limited will close its trading window for directors, officers, designated persons, and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ended September 30, 2026, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015.

1 month agoCapital Market - Live
Corporate
Corporate
Soni Medicare Limited’s 38th Annual General Meeting is scheduled for September 29, 2025, in Jaipur

Soni Medicare Limited will hold its 38th Annual General Meeting on September 29, 2025, at 3:00 P.M. in Jaipur, and the company’s register of members and share transfer books will be closed from September 23, 2026, to September 29, 2026, with September 22, 2026, set as the cut-off date for e-voting eligibility, and remote e-voting commencing on September 26, 2026, and ending on September 28, 2026.

1 month agoCapital Market - Live
Corporate
Corporate
Soni Medicare’s board approved financial report and scheduled AGM for September 29 in Jaipur

Soni Medicare Limited informed the BSE Limited that its board of directors approved the board report for the financial year ended March 31, 2026, and convened the 38th Annual General Meeting for September 29, 2026, at 38, Kanota Bagh, Jawaharlal Nehru Marg, Jaipur. The company also appointed M/s. Mahendra Khandelwal & Company as the scrutinizer for the AGM, approved changes in designations for Mr. Namit Soni and Mr. Lavi Kumar Mutha, and approved increases in limits under sections 186 and 185 of the Companies Act, 2013, up to Rs 100 crores in each case, all subject to member approval.

2 months agoCapital Market - Live
Corporate
Corporate
Soni Medicare appoints Namit Soni as Additional Executive Director through August 2026

Soni Medicare Limited announced the appointment of Mr. Namit Soni as Additional Executive Director, effective August 14, 2026, and continuing until the company's next Annual General Meeting. Mr. Soni, whose appointment was approved by the board on Friday, August 14, 2026, holds a degree from St. Stephens’ College and an MBA from IMI, New Delhi, and is the son of Chairman and MD Mr. Bimal Roy Soni and Non-Executive Director Mrs. Anju Soni.

2 months agoCapital Market - Live
Earnings
Earnings
Soni Medicare reports standalone net loss of Rs 0.37 crore in the March 2026 quarter

Net loss of Soni Medicare reported to Rs 0.37 crore in the quarter ended March 2026 as against net profit of Rs 0.35 crore during the previous quarter ended March 2025. Sales declined 15.14% to Rs 5.83 crore in the quarter ended March 2026 as against Rs 6.87 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 2.71 crore in the year ended March 2026 as against net loss of Rs 0.19 crore during the previous year ended March 2025. Sales declined 17.19% to Rs 24.71 crore in the year ended March 2026 as against Rs 29.84 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales5.836.87 -15 24.7129.84 -17 OPM %3.0910.19 --3.684.22 - PBDT-0.180.41 PL -2.130.27 PL PBT-0.310.26 PL -2.64-0.23 -1048 NP-0.370.35 PL -2.71-0.19 -1326 Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Corporate
Soni Medicare to discuss results

Soni Medicare will hold a meeting of the Board of Directors of the Company on 30 May 2026.

5 months agoCapital Market - Live
Earnings
Earnings
Soni Medicare reports standalone net loss of Rs 1.13 crore in the December 2025 quarter

Net Loss of Soni Medicare reported to Rs 1.13 crore in the quarter ended December 2025 as against net loss of Rs 0.13 crore during the previous quarter ended December 2024. Sales declined 28.72% to Rs 5.36 crore in the quarter ended December 2025 as against Rs 7.52 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales5.367.52 -29 OPM %-12.313.46 - PBDT-1.000.02 PL PBT-1.13-0.10 -1030 NP-1.13-0.13 -769 Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Corporate
Soni Medicare schedules board meeting

Soni Medicare will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live

8 months agoCapital Market - Live

Frequently asked questions

  1. The share price of SML as on 24th August 2026 is ₹69.35. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of Soni Medicare Ltd (SML) share are
    • Past 1 week: N/A%
    • Past 1 month: N/A%
    • Past 3 months: 8.72%
    • Past 6 months: 16.42%
    • Past 1 year: -10.91%
    • Past 3 years: 169.01%
    • Past 5 years: 127.38%

  3. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Soni Medicare Ltd (SML) is ₹31.13 Cr as of 24th August 2026.

  4. The 52-week high of Soni Medicare Ltd (SML) is ₹109.70 and the 52-week low is ₹43.82.

  5. The P/E (price-to-earnings) ratio of Soni Medicare Ltd (SML) is -11.49. The P/B (price-to-book) ratio is 24.13.

  6. Soni Medicare Ltd (SML) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  7. You can directly buy Soni Medicare Ltd (SML) shares on Tickertape. Simply sign up, connect your demat account and place your order.